Featured Research

from universities, journals, and other organizations

New class of drugs may affect cancer and aging

Date:
August 13, 2012
Source:
University of South Carolina
Summary:
An international team has reported the development of a new class of drugs that may prove useful in the treatment of cancer and aging-associated disorders.

In a study published in the Proceedings of the National Academy of Sciences (PNAS) on Aug. 6, an international team led by Igor Roninson, of the University of South Carolina and the Medical University of South Carolina, reported the development of a new class of drugs that may prove useful in the treatment of cancer and aging-associated disorders.

In 2000, Roninson led a group that reported in PNAS that a single protein, called p21, turns on multiple genes implicated in cancer and in other disorders associated with advanced age such as Alzheimer's disease and arthritis. These harmful changes are especially prominent in senescent (aged) cells. Senescence in cells arises with the passage of time, but it can also be brought on after damage by various factors, including chemotherapeutic drugs and radiation used in cancer treatment.

Since the original discovery, Roninson has sought to understand the mechanism of this surprising effect of p21 and develop drugs that would block the harmful effects of senescent cells in different diseases. In the Aug. 6 publication, Roninson and colleagues reported a solution to this puzzle that holds significant therapeutic promise.

The gene expressing p21 is turned on in damaged cells, and the protein stops these cells from dividing by binding to enzymes that are called cyclin-dependent kinases (CDKs). The best-known CDKs are essential for cell division, and p21 binding inhibits their activity. The new study reports that the disease-promoting effects of p21 are mediated, at least in part, by its effect on a different CDK, called CDK8, which regulates the activity of many different genes but is not required for cell division. In contrast to its effect on other CDKs, p21 stimulates rather than inhibits CDK8, turning on multiple CDK8-regulated genes. Roninson's team, together with Senex Biotechnology, a company he founded, has developed a new class of drugs that inhibit CDK8, and they showed that these drugs overcome some of the most troublesome effects of cancer chemotherapy.

Chemotherapy can shrink or even eliminate tumors, but it also wreaks havoc on the rest of the body, damaging normal tissues. Among other harmful effects, chemotherapy causes damaged cells to produce molecules that promote the growth, drug resistance and the spread of those tumor cells that survived the treatment. Co-author Hippokratis Kiaris of the University of Athens (Greece) demonstrated this adverse effect of chemotherapy by treating healthy mice with a common chemotherapy drug, allowing the mice to recover, and then injecting them with cancer cells. These mice, having undergone a chemotherapy-like regimen, developed tumors much more efficiently than a control group not treated with the anticancer drug.

Furthermore, the blood of the mice pre-treated with the anticancer drug contained a higher amount of proteins that stimulate the growth of tumor cells. However, when the mice were injected with Senexin A, a synthetic CDK8 inhibitor developed by Roninson's team, the anticancer drug no longer stimulated the growth of tumors. The CDK8 inhibitor also increased the ability of the anticancer drug, when injected in tumor-bearing animals, to destroy the tumors. While the CDK8 inhibitor stopped the production of the harmful proteins by senescent cells, it did not reverse senescence, which is a necessary cancer-preventive program in our cells. By creating a synthetic chemical that can inhibit the harmful effects of senescence, the team offers a new pharmacological approach to treating cancer and potentially age-related diseases such as Alzheimer's, atherosclerosis and arthritis.


Story Source:

The above story is based on materials provided by University of South Carolina. Note: Materials may be edited for content and length.


Journal Reference:

  1. D. C. Porter, E. Farmaki, S. Altilia, G. P. Schools, D. K. West, M. Chen, B.-D. Chang, A. T. Puzyrev, C.-u. Lim, R. Rokow-Kittell, L. T. Friedhoff, A. G. Papavassiliou, S. Kalurupalle, G. Hurteau, J. Shi, P. S. Baran, B. Gyorffy, M. P. Wentland, E. V. Broude, H. Kiaris, I. B. Roninson. Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities. Proceedings of the National Academy of Sciences, 2012; DOI: 10.1073/pnas.1206906109

Cite This Page:

University of South Carolina. "New class of drugs may affect cancer and aging." ScienceDaily. ScienceDaily, 13 August 2012. <www.sciencedaily.com/releases/2012/08/120813172638.htm>.
University of South Carolina. (2012, August 13). New class of drugs may affect cancer and aging. ScienceDaily. Retrieved September 23, 2014 from www.sciencedaily.com/releases/2012/08/120813172638.htm
University of South Carolina. "New class of drugs may affect cancer and aging." ScienceDaily. www.sciencedaily.com/releases/2012/08/120813172638.htm (accessed September 23, 2014).

Share This



More Health & Medicine News

Tuesday, September 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Liberia Pleads for Help to Fight Ebola

Liberia Pleads for Help to Fight Ebola

AP (Sep. 22, 2014) Liberia's finance minister is urging the international community to quickly follow through on pledges of cash to battle Ebola. Bodies are piling up in the capital Monrovia as the nation awaits more help. (Sept. 22) Video provided by AP
Powered by NewsLook.com
Ebola Doctor Says Border Controls Critical

Ebola Doctor Says Border Controls Critical

AP (Sep. 22, 2014) A Florida doctor who helped fight the expanding Ebola outbreak in West Africa says the disease can be stopped, but only if nations quickly step up their response and make border control a priority. (Sept. 22) Video provided by AP
Powered by NewsLook.com
Global Ebola Aid Increasing But Critics Say It's Late

Global Ebola Aid Increasing But Critics Say It's Late

Newsy (Sep. 21, 2014) More than 100 tons of medical supplies were sent to West Africa on Saturday, but aid workers say the global response is still sluggish. Video provided by Newsy
Powered by NewsLook.com
Sierra Leone in Lockdown to Control Ebola

Sierra Leone in Lockdown to Control Ebola

AP (Sep. 21, 2014) Sierra Leone residents remained in lockdown on Saturday as part of a massive effort to confine millions of people to their homes in a bid to stem the biggest Ebola outbreak in history. (Sept. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

More Coverage


New Approach to Improving Cancer Chemotherapy

Aug. 7, 2012 A team of researchers has reported the discovery of a new class of drugs that reduces the adverse effects of cellular damage from ... read more

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins